STANDARD BIOTOOLS INC. (LAB) Gross margin 2016–2025
STANDARD BIOTOOLS INC. (LAB) gross margin by fiscal year — reported gross profit divided by reported revenue.
49.9%FY2025 · since FY2016: 55.9% → 49.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 49.9% | +0.5 pp |
| FY2024 | 49.3% | +1.9 pp |
| FY2023 | 47.4% | +9.6 pp |
| FY2022 | 37.8% | — |
| FY2019 | 54.8% | +0.3 pp |
| FY2018 | 54.6% | +3.6 pp |
| FY2017 | 51.0% | -5.0 pp |
| FY2016 | 55.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice